Market Exclusive

Analyst Activity – Sanford C. Bernstein Initiates Coverage On Spark Therapeutics (NASDAQ:ONCE) With a Outperform

Analyst Ratings For Spark Therapeutics (NASDAQ:ONCE)

Today, Sanford C. Bernstein initiated coverage on Spark Therapeutics (NASDAQ:ONCE) with a Outperform.

There are 1 sell rating, 1 hold rating, 9 buy ratings on the stock.

The current consensus rating on Spark Therapeutics (NASDAQ:ONCE) is Buy (Score: 2.73) with a consensus target price of $71.28 per share, a potential 1.93% downside.

Some recent analyst ratings include

Recent Insider Trading Activity For Spark Therapeutics (NASDAQ:ONCE)
Spark Therapeutics (NASDAQ:ONCE) has insider ownership of 7.30% and institutional ownership of 88.94%.

Recent Trading Activity for Spark Therapeutics (NASDAQ:ONCE)
Shares of Spark Therapeutics closed the previous trading session at 73.51 up +0.83 1.14% with 243,876 shares trading hands.

Exit mobile version